
Sign up to save your podcasts
Or
Join us to hear about the latest advancements in immunotherapy for advanced, intermediate-, and early-stage hepatocellular carcinoma (HCC).
Credit available for this activity expires: 11/18/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001794?ecd=bdc_podcast_libsyn_mscpedu
4
77 ratings
Join us to hear about the latest advancements in immunotherapy for advanced, intermediate-, and early-stage hepatocellular carcinoma (HCC).
Credit available for this activity expires: 11/18/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001794?ecd=bdc_podcast_libsyn_mscpedu
130 Listeners
13 Listeners
319 Listeners
862 Listeners
494 Listeners
692 Listeners
18 Listeners
274 Listeners
254 Listeners
3,320 Listeners
260 Listeners
87 Listeners
1,081 Listeners
186 Listeners
514 Listeners
320 Listeners
59 Listeners
25 Listeners
289 Listeners